(in millions) | ||||||||||
as of September 30, 2013 | Fair Value | Valuation Technique | Significant Unobservable Inputs | Range (Weighted Average) | ||||||
Life settlement contracts | $ | 13.8 | Discounted cash flow | Life expectancy | 25–160 months (76) | |||||
Discount rate | 3.3%–21.7% (11.7%) | |||||||||
Contingent consideration liabilities | 97.7 | Discounted cash flow | AUM growth rate | 6.0%–25.0% (14.6%) | ||||||
EBITDA margin | 26.4% - 38.9% (34.4%) | |||||||||
Discount rate | 14.0% | |||||||||
(in millions) | ||||||||||
as of September 30, 2012 | Fair Value | Valuation Technique | Significant Unobservable Inputs | Range (Weighted Average) | ||||||
Life settlement contracts | $ | 12.1 | Discounted cash flow | Life expectancy | 22–171 months (82) | |||||
Discount rate | 1.5%–22.3% (11.7%) | |||||||||